Compositions and methods for treating cancer

a cancer and composition technology, applied in the field of compositions and methods for treating cancer, can solve the problems of almost entirely unsuccessful attempts to directly target this enzyme with reversible inhibitors

Inactive Publication Date: 2015-03-26
RGT UNIV OF CALIFORNIA
View PDF0 Cites 63 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, past attempts to directly target this enzyme with reversible inhibitors have been almost entirely unsuccessful.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for treating cancer
  • Compositions and methods for treating cancer
  • Compositions and methods for treating cancer

Examples

Experimental program
Comparison scheme
Effect test

embodiment 1

[0364]2. The compound of embodiment 1, wherein R1 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

[0365]3. The compound of embodiment 1, wherein R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

[0366]4. The compound of embodiment 1, wherein R1 is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl.

[0367]5. The compound of embodiment 1, wherein R1 is substituted or unsubstituted fused ring aryl or substituted or unsubstituted fused ring heteroaryl.

[0368]6. The compound of embodiment 1, wherein R1 is R3-substituted or unsubstituted aryl or R3-substituted or unsubstituted heteroaryl; wherein, R3 is independently hydrogen, oxo, halogen,...

embodiment 10

[0374]12. The compound of embodiment 10, wherein L1 is independently substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, substituted or unsubstituted heteroarylene, or substituted or unsubstituted spirocyclic linker; or L2 is independently substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, substituted or unsubstituted heteroarylene, or substituted or unsubstituted spirocyclic linker; or L3 is independently substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, substituted or unsubstituted heteroarylene, or substituted or unsubstituted spirocyclic linker.

[0375]13. The compound of embodiment 10, wherein L1 is independently R2C-substituted or unsubstituted cycloalkylene, R2C-substituted or unsubstituted heterocycloalkylene, R2C-substituted or unsubstit...

embodiment 19

[0382]20. The method of embodiment 19, wherein said disease is cancer.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
distanceaaaaaaaaaa
distanceaaaaaaaaaa
distanceaaaaaaaaaa
Login to view more

Abstract

K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.

Description

RELATED APPLICATIONS[0001]This application claims the benefit of U.S. Provisional Patent Application Nos. 61 / 622,507, filed Apr. 10, 2012; 61 / 728,145, filed Nov. 19, 2012; and 61 / 794,956, filed Mar. 15, 2013, which are all incorporated herein by reference in their entirety and for all purposes.REFERENCE TO A “SEQUENCE LISTING,” A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED AS AN ASCII TEXT FILE[0002]The Sequence Listing written in file 84850-869921_ST25.TXT, created on Apr. 9, 2013, 28,573 bytes, machine format IBM-PC, MS-Windows operating system, is hereby incorporated by reference.BACKGROUND OF THE INVENTION[0003]K-Ras is the most frequently mutated oncogene in human cancer. However, past attempts to directly target this enzyme with reversible inhibitors have been almost entirely unsuccessful.[0004]Ras proteins are small guanine nucleotide-binding proteins that act as molecular switches by cycling between active GTP-bound and inactive GDP-bound conformations. Ras signa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D487/04C07D401/12C12N9/14C07D211/62C07D409/04C07D401/06C07D211/58
CPCC07D487/04C07D401/06C07D401/12C07D211/58C07D211/62C07D409/04C12N9/14C12Y306/05002A61K38/1709C07D207/14C07D231/40C07D295/185C07D295/26C07D401/04C07D405/12C07D413/12C07D417/12C07D471/10C07D487/10C07D495/04G01N2500/04A61P35/00A61P35/02A61P43/00C07C235/20C07C317/08C12Q1/6886C12Q2600/156C12Q2600/158
Inventor OSTREM, JONATHANPETERS, ULFSHOKAT, KEVAN M.
Owner RGT UNIV OF CALIFORNIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products